Managing gastro-oesophageal reflux in infants

BMJ (Online)

Volumn 341, Issue 7771, 2010, Pages 495-498

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; DOMPERIDONE; FAMOTIDINE; GAVISCON; LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; RANITIDINE;

AGITATION; ASTHMA; BEHAVIOR DISORDER; CASE MANAGEMENT; CHILD CARE; CLINICAL FEATURE; DIARRHEA; DIET THERAPY; DRUG INDICATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFANT FEEDING; IRRITABILITY; LIFESTYLE MODIFICATION; LOWER RESPIRATORY TRACT INFECTION; PATHOPHYSIOLOGY; PATIENT POSITIONING; PRIORITY JOURNAL; QT PROLONGATION; RASH; REVIEW; SIDE EFFECT; SOMNOLENCE; TARDIVE DYSKINESIA; TREATMENT PLANNING;

EID: 77956285050     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c4420     Document Type: Review

References (51)

1. Managing childhood gastro-oesophageal reflux. DTB 1997;35:77-80.
2. Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2009;49:498-547.
3. Khoshoo V, Edell D, Thompson A, Rubin M. Are we overprescribing antireflux medications for infants with regurgitation? Pediatrics 2007;120:946-9. (Pubitemid 350085526)
4. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr 2007;45:421-7. (Pubitemid 350307159)
5. Newell SJ, Booth IW, Morgan ME, Durbin GM, McNeish AS. Gastrooesophageal reflux in preterm infants. Arch Dis Child 1989;64:780-6.
6. Nelson SP, Chen EH, Syniar GM, Kaufer Christoffel K. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Arch Pediatr Adolesc Med 1997;151:569-72.
7. Nielsen RG, Bindslev-Jensen C, Kruse-Andersen S, Husby S. Severe gastroesophageal reflux disease and cow milk hypersensitivity in infants and children: disease association and evaluation of a new challenge procedure. J Pediatr Gastroenterol Nutr 2004;39:383-91.
8. Iacono G, Carroccio A, Cavataio F, Montalto G, Kazmierska I, Lorello D, et al. Gastroesophageal reflux and cow's milk allergy in infants: a prospective study. J Allergy Clin Immunol 1996;97:822-7.
9. Davies AEM, Sandhu BK. Diagnosis and treatment of gastro-oesophageal reflux. Arch Dis Child 1995;73:82-6.
10. Vandenplas Y. Reflux esophagitis in infants and children: a report from the working group on gastro-oesophageal reflux disease of the European Society of Paediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1994;18:413-22. (Pubitemid 24164668)
11. Tolia V, Vandenplas Y. Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children. Aliment Pharmacol Ther 2009;29:258-72.
12. Hrabovsky EE, Mullett MD. Gastroesophageal reflux and the premature infant. J Pediatr Surg 1986;21:583-7.
13. Birch JL, Newell SJ. Gastroesophageal reflux disease in preterm infants-current management and diagnostic dilemmas. Arch Dis Child Fetal Neonatal Ed 2009 published online doi:10.1136/adc.2008.149112.
14. Wenzl TG. Evaluation of gastroesophageal reflux events in children using multichannel intraluminal electrical impedance. Am J Med 2003;115:161-5S.
15. Dahms BB. Reflux oesophagitis: sequelae and differential diagnosis in infants and children including eosinophilic esophagitis. Pediatr Dev Pathol 2004;7:5-16.
16. Meyers WF, Roberts CC, Johnson DG, Herbst JJ. Value of tests for evaluation of gastroesophageal reflux in children. J Pediatr Surg 1985;20:515-20.
17. Simanovsky N, Buonomo C, Nurko S. The infant with chronic vomiting: the value of the upper GI series. Pediatr Radiol 2002;32:549-50. (Pubitemid 36075742)
18. Barak M, Lahav S, Mimouni FB, Dollberg S. The prevalence of regurgitations in the first 2 days of life in human milk- and formula-fed term infants. Breastfeed Med 2006;1:168-71.
19. Cavataio F, Iacono G, Montalto G, Soresi M, Tumminello M, Carroccio A. Clinical and pH-metric characteristics of gastro-oesophageal reflux secondary to cows' milk protein allergy. Arch Dis Child 1996;75:51-6. (Pubitemid 26249078)
20. Semeniuk J, Kaczmarski M. Gastroesophageal reflux in children and adolescents. Clinical aspects with special respect to food hypersensitivity. Adv Med Sci 2006;51:327-35.
21. Hill DJ, Heine RG, Cameron DJ, Catto-Smith AG, Chow CW, Francis DE, et al. Role of food protein intolerance in infants with persistent distress attributed to reflux oesophagitis. J Pediatr 2000;136:641-7.
22. Ferry GD, Selby M, Pietro TJ. Clinical response to short-term nasogastric feeding in infants with gastroesophageal reflux and growth failure. J Pediatr Gastroenterol Nutr 1983;2:57-61. (Pubitemid 13117805)
23. Horvath A, Dziechciarz P, Szajewska H.The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics 2008;122:e1268-77.
24. Chao HC, Vandenplas Y. Comparison of the effect of a cornstarch thickened formula and strengthened regular formula on regurgitation, gastric emptying and weight gain in infantile regurgitation. Dis Esophagus 2007;20:155-60.
25. Craig WR, Hanlon-Dearman A, Sinclair C, Taback SP, Moffatt M. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. Cochrane Database Syst Rev 2004;(3):CD003502.
26. Corvaglia L, Rotatori R, Ferlini M, Aceti A, Ancora G, Faldella G. The effect of body positioning on gastroesophageal reflux in premature infants: evaluation by combined impedance and pH monitoring. J Pediatr 2007;151:591-6.
27. Van Wijk MP, Benninga MA, Dent J, Lontis R, Goodchild L, McCall LM, et al. Effect of body position changes on postprandial gastroesophageal reflux and gastric emptying in the healthy premature neonate. J Pediatr 2007;151:585-90.
28. American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics 2005;116:1245-55.
29. Tighe MP, Afzal NA, Bevan A, Beattie RM. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. Paediatr Drugs 2009;11:185-202.
30. Paediatric Formulary Committee. BNF for children 2009. BMJ Group, RPS Publishing, 2009.
31. Miller S. Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Curr Med Res Opin 1999;15:160-8.
32. Del Buono R, Wenzl TG, Ball G, Keady S, Thomson M. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH. Arch Dis Child 2005;90:460-3.
33. Gaviscon Infant. Summary of product characteristics, UK. Reckitt Benckiser Healthcare (UK), August 2003.
34. Cucchiara S, Staiano A, Romaniello G, Capobianco S, Auricchio S. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child 1984;59:842-7.
35. Orenstein SR, Shalaby TM, Devandry SN, Liacouras CA, Czinn SJ, Dice JE, et al. Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial. Aliment Pharmacol Ther 2003;17:1097-107.
36. Tagamet syrup. Summary of product characteristics, UK. Chemidex Pharma, February 2009.
37. Zantac injection 50mg/2mL. Summary of product characteristics, UK. Glaxo Wellcome UK, March 2009.
38. Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr 2007;44:41-4.
39. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009;154:514-20.
40. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007;150:262-7.
41. Tolia V, Fitzgerald J, Hassall E, Huang B, Pilmer B, Kane R 3rd. Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr 2002;35:S300-7.
42. Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117:e817-20.
43. Guillet R, Stoll BJ, Cotten CM, Gantz M, McDonald S, Poole WK, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006;117:137-42.
44. Saiman L, Ludington E, Dawson JD, Patterson JE, Rangel-Frausto S, Wiblin RT, et al. Risk factors for candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001;20:1119-24.
45. Perrio M, Voss S, Shakir SA. Application of the Bradford Hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance. Drug Saf 2007;30:333-46.
46. Djeddi D, Kongolo G, Lefaix C, Mounard J, Léké A. Effect of domperidone on QT interval in neonates. J Pediatr 2008;153:663-6.
47. Pritchard DS, Baber N, Stephenson T. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol 2005;59:725-9. (Pubitemid 40835508)
48. Cresi F, Marinaccio C, Russo MC, Miniero R, Silvestro L. Short-term effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring. J Perinatol 2008;28:766-70.
49. Hibbs AM, Lorch SA. Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. Pediatrics 2006;118:746-52.
50. Hassall E. Outcomes of fundoplication: causes for concern, newer options. Arch Dis Child 2005;90:1047-52. (Pubitemid 41406613)
51. Lobe TE. The current role of laparoscopic surgery for gastroesophageal reflux disease in infants and children. Surg Endosc 2007;21:167-74.